Cargando…

Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8

Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Yuki, Iwamoto, Fumihiko, Ishida, Yasuaki, Kuno, Toru, Kobayashi, Shoji, Yoshida, Takashi, Yamaguchi, Tatsuya, Sato, Tadashi, Sudo, Makoto, Ichikawa, Daisuke, Enomoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609388/
https://www.ncbi.nlm.nih.gov/pubmed/32388943
http://dx.doi.org/10.5217/ir.2019.09141
_version_ 1783605022623268864
author Mori, Yuki
Iwamoto, Fumihiko
Ishida, Yasuaki
Kuno, Toru
Kobayashi, Shoji
Yoshida, Takashi
Yamaguchi, Tatsuya
Sato, Tadashi
Sudo, Makoto
Ichikawa, Daisuke
Enomoto, Nobuyuki
author_facet Mori, Yuki
Iwamoto, Fumihiko
Ishida, Yasuaki
Kuno, Toru
Kobayashi, Shoji
Yoshida, Takashi
Yamaguchi, Tatsuya
Sato, Tadashi
Sudo, Makoto
Ichikawa, Daisuke
Enomoto, Nobuyuki
author_sort Mori, Yuki
collection PubMed
description Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furthermore, there is a relationship between MDS in patients with intestinal BD and trisomy 8. Immunosuppressive agents alone are insufficient to control MDS-associated BD, and many of these patients die of infection or hemorrhage. Surgery is considered for intestinal BD patients who are unresponsive to medical treatment or those with bowel complications such as perforation or persistent bleeding. We report a case of intestinal BD associated with MDS and trisomy 8. The patient was unresponsive to oral steroids and immunosuppressive treatment; the patient improved by surgical repair of a bowel perforation. Five years after the surgery, the patient is free of recurrence and not on medication. Our experience suggests that surgery may provide an effective therapeutic option for the treatment of MDS-related BD.
format Online
Article
Text
id pubmed-7609388
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-76093882020-11-10 Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 Mori, Yuki Iwamoto, Fumihiko Ishida, Yasuaki Kuno, Toru Kobayashi, Shoji Yoshida, Takashi Yamaguchi, Tatsuya Sato, Tadashi Sudo, Makoto Ichikawa, Daisuke Enomoto, Nobuyuki Intest Res Case Report Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furthermore, there is a relationship between MDS in patients with intestinal BD and trisomy 8. Immunosuppressive agents alone are insufficient to control MDS-associated BD, and many of these patients die of infection or hemorrhage. Surgery is considered for intestinal BD patients who are unresponsive to medical treatment or those with bowel complications such as perforation or persistent bleeding. We report a case of intestinal BD associated with MDS and trisomy 8. The patient was unresponsive to oral steroids and immunosuppressive treatment; the patient improved by surgical repair of a bowel perforation. Five years after the surgery, the patient is free of recurrence and not on medication. Our experience suggests that surgery may provide an effective therapeutic option for the treatment of MDS-related BD. Korean Association for the Study of Intestinal Diseases 2020-10 2020-05-12 /pmc/articles/PMC7609388/ /pubmed/32388943 http://dx.doi.org/10.5217/ir.2019.09141 Text en © Copyright 2020. Korean Association for the Study of Intestinal Diseases. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mori, Yuki
Iwamoto, Fumihiko
Ishida, Yasuaki
Kuno, Toru
Kobayashi, Shoji
Yoshida, Takashi
Yamaguchi, Tatsuya
Sato, Tadashi
Sudo, Makoto
Ichikawa, Daisuke
Enomoto, Nobuyuki
Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
title Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
title_full Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
title_fullStr Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
title_full_unstemmed Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
title_short Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
title_sort long-term outcome after surgery in a patient with intestinal behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609388/
https://www.ncbi.nlm.nih.gov/pubmed/32388943
http://dx.doi.org/10.5217/ir.2019.09141
work_keys_str_mv AT moriyuki longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT iwamotofumihiko longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT ishidayasuaki longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT kunotoru longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT kobayashishoji longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT yoshidatakashi longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT yamaguchitatsuya longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT satotadashi longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT sudomakoto longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT ichikawadaisuke longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8
AT enomotonobuyuki longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8